The MS4A1 protein, also known as CD20, has been shown to be upregulated, and targetable, in chronic lymphocytic leukemia (Pavlasova et al., 2016) and expressed in leukemic stem cells in ALL (Blatt et al., 2018). This evidence concerns the gene MS4A1 and B-cell chronic lymphocytic leukemia.